Summary
The global and Chinese economies were hit hard in 2020, and the global GDP grew by XX% in 2021. Although the global growth prospects improved and there was a V-shaped rebound, this does not mean that the economy has really recovered to the level before the epidemic. The vast majority of countries are still in the stage of recovery after heavy damage and are far from achieving real recovery.
2023 is a year of continuous recovery. Global supply chain disturbance, geopolitical tension, energy price fluctuation, local labor shortage and rising raw material prices will affect the resilience of economic recovery. The International Monetary Fund (IMF) predicts that the world economy will grow by XX% in 2023, of which the U.S. economy will grow by about XX%. Driven by China and India, Asia is expected to become the fastest growing region in the world in 2023. However, China's economic growth has slowed down. The 2023 government work report shows that the expected target of economic growth is set at about XX%.
According to research, China has set a growth rate of about XX%, which not only focuses on the speed of economic growth, but also anchors the quality of economic development. Scientific and technological innovation, economic and social digitization and green development will be the long-term goals of China's economic development. It is expected that in 2023, major economies such as the United States, Europe and China will introduce more favorable policies to drive the development of switching power supply industry.
VIC Research released the 《Global Pharmaceutical Hot Melt Extrusion Market Segment Research Report 2023》, which aims to sort out the development status and trends of the Pharmaceutical Hot Melt Extrusion industry at home and abroad, estimate the overall market scale of the Pharmaceutical Hot Melt Extrusion industry and the market share of major countries, Pharmaceutical Hot Melt Extrusion industry, and study and judge the downstream market demand of Pharmaceutical Hot Melt Extrusion through systematic research, Analyze the competition pattern of Pharmaceutical Hot Melt Extrusion, so as to help solve the pain points of various stakeholders in Pharmaceutical Hot Melt Extrusion industry. This industry research report combines desktop research, qualitative interviews with insiders or experts and other methods to strive for the objectivity and integrity of conclusions and data.
Regional Segmentation (Value; Revenue, USD Million, 2019-2028) of Pharmaceutical Hot Melt Extrusion Market by VIC Research Include
USA
Europe
China
Japan
India
Korea
Southeast Asia
Competitive Analysis; Who are the Major Players in Pharmaceutical Hot Melt Extrusion Market?
Milacron Holdings
Coperion GmbH
Gabler GmbH&Co. KG
Umang
Major Type of Pharmaceutical Hot Melt Extrusion Covered in VIC Research report:
Twin Screw Extruder
Single Screw Extruder
Laboratory Extruder
RAM Extruder
Application Segments Covered in VIC Research Market
Research Laboratory
Contract Manufacturing Organization
Pharma Companies
For any other requirements, please feel free to contact us and we will provide you customized report.
Table of Contents
Global Pharmaceutical Hot Melt Extrusion Market Segment Research Report 2023
1. Research Scope
2. Market Overview
2.1 Product Introduction, Application, Picture
2.2 Global Pharmaceutical Hot Melt Extrusion Market by Value
2.2.1 Global Pharmaceutical Hot Melt Extrusion Revenue by Type
2.2.2 Global Pharmaceutical Hot Melt Extrusion Market by Value
2.3 Global Pharmaceutical Hot Melt Extrusion Market by Sales
2.3.1 Global Pharmaceutical Hot Melt Extrusion Sales by Type
2.3.2 Global Pharmaceutical Hot Melt Extrusion Market by Sales
3. The Major Driver of Pharmaceutical Hot Melt Extrusion Industry
3.1 Historical & Forecast Global Pharmaceutical Hot Melt Extrusion Sales and Revenue (2019-2028)
3.2 Largest Application for Pharmaceutical Hot Melt Extrusion (2019-2028)
3.3 The Major Downstream Company in China Market 2023
4. Global and Regional Pharmaceutical Hot Melt Extrusion Market
4.1 Regional Market Size in Terms of Sales (2023 & 2028)
4.2 Regional Market Share in Terms of Revenue (2023 & 2028)
4.3 Concentration Ratio (CR5& CR10) of Pharmaceutical Hot Melt Extrusion Market
4.4 Mergers & Acquisitions, Expansion Plans
5. US Pharmaceutical Hot Melt Extrusion Sales (2019-2028)
5.1 Current and Estimated Sales Breakdown by Type (2019-2028)
5.2 Current and Estimated Sales Breakdown by Application (2019-2028)
5.3 Current and Estimated Revenue Breakdown by Type (2019-2028)
5.4 Current and Estimated Revenue Breakdown by Application (2019-2028)
6. Europe Pharmaceutical Hot Melt Extrusion Sales (2019-2028)
6.1 Current and Estimated Sales Breakdown by Type (2019-2028)
6.2 Current and Estimated Sales Breakdown by Application (2019-2028)
6.3 Current and Estimated Revenue Breakdown by Type (2019-2028)
6.4 Current and Estimated Revenue Breakdown by Application (2019-2028)
7. China Pharmaceutical Hot Melt Extrusion Sales (2019-2028)
7.1 Current and Estimated Sales Breakdown by Type (2019-2028)
7.2 Current and Estimated Sales Breakdown by Application (2019-2028)
7.3 Current and Estimated Revenue Breakdown by Type (2019-2028)
7.4 Current and Estimated Revenue Breakdown by Application (2019-2028)
8. Japan Pharmaceutical Hot Melt Extrusion Sales (2019-2028)
8.1 Current and Estimated Sales Breakdown by Type (2019-2028)
8.2 Current and Estimated Sales Breakdown by Application (2019-2028)
8.3 Current and Estimated Revenue Breakdown by Type (2019-2028)
8.4 Current and Estimated Revenue Breakdown by Application (2019-2028)
9. India Pharmaceutical Hot Melt Extrusion Sales (2019-2028)
9.1 Current and Estimated Sales Breakdown by Type (2019-2028)
9.2 Current and Estimated Sales Breakdown by Application (2019-2028)
9.3 Current and Estimated Revenue Breakdown by Type (2019-2028)
9.4 Current and Estimated Revenue Breakdown by Application (2019-2028)
10. Korea Pharmaceutical Hot Melt Extrusion Sales (2019-2028)
10.1 Current and Estimated Sales Breakdown by Type (2019-2028)
10.2 Current and Estimated Sales Breakdown by Application (2019-2028)
10.3 Current and Estimated Revenue Breakdown by Type (2019-2028)
10.4 Current and Estimated Revenue Breakdown by Application (2019-2028)
11. Southeast Asia Pharmaceutical Hot Melt Extrusion Sales (2019-2028)
11.1 Current and Estimated Sales Breakdown by Type (2019-2028)
11.2 Current and Estimated Sales Breakdown by Application (2019-2028)
11.3 Current and Estimated Revenue Breakdown by Type (2019-2028)
11.4 Current and Estimated Revenue Breakdown by Application (2019-2028)
12. South America Pharmaceutical Hot Melt Extrusion Sales (2019-2028)
12.1 Current and Estimated Sales Breakdown by Type (2019-2028)
12.2 Current and Estimated Sales Breakdown by Application (2019-2028)
12.3 Current and Estimated Revenue Breakdown by Type (2019-2028)
12.4 Current and Estimated Revenue Breakdown by Application (2019-2028)
13. Global Pharmaceutical Hot Melt Extrusion Average Price Trend
13.1 Market Price for Each Type of Pharmaceutical Hot Melt Extrusion in US (2019-2023)
13.2 Market Price for Each Type of Pharmaceutical Hot Melt Extrusion in Europe (2019-2023)
13.3 Market Price for Each Type of Pharmaceutical Hot Melt Extrusion in China (2019-2023)
13.4 Market Price for Each Type of Pharmaceutical Hot Melt Extrusion in Japan (2019-2023)
13.5 Market Price for Each Type of Pharmaceutical Hot Melt Extrusion in India (2019-2023)
13.6 Market Price for Each Type of Pharmaceutical Hot Melt Extrusion in Korea (2019-2023)
13.7 Market Price for Each Type of Pharmaceutical Hot Melt Extrusion in Southeast Asia (2019-2023)
13.8 Market Price for Each Type of Pharmaceutical Hot Melt Extrusion in South America (2019-2023)
14. Industrial Chain (Impact of COVID-19)
14.1 Pharmaceutical Hot Melt Extrusion Industrial Chain Analysis
14.2 Downstream
14.3 Impact of COVID-19
14.4 Post-pandemic Era
14.5 Technology Trends of Pharmaceutical Hot Melt Extrusion
15. Pharmaceutical Hot Melt Extrusion Competitive Landscape
15.1 Milacron Holdings
15.1.1 Milacron Holdings Company Profiles
15.1.2 Milacron Holdings Product Introduction
15.1.3 Milacron Holdings Pharmaceutical Hot Melt Extrusion Sales, Revenue (2019-2023)
15.1.4 Strategic initiatives
15.2 Coperion GmbH
15.2.1 Coperion GmbH Company Profiles
15.2.2 Coperion GmbH Product Introduction
15.2.3 Coperion GmbH Pharmaceutical Hot Melt Extrusion Sales, Revenue (2019-2023)
15.2.4 Strategic initiatives
15.3 Gabler GmbH&Co. KG
15.3.1 Gabler GmbH&Co. KG Company Profiles
15.3.2 Gabler GmbH&Co. KG Product Introduction
15.3.3 Gabler GmbH&Co. KG Pharmaceutical Hot Melt Extrusion Sales, Revenue (2019-2023)
15.3.4 Strategic initiatives
15.4 Umang
15.4.1 Umang Company Profiles
15.4.2 Umang Product Introduction
15.4.3 Umang Pharmaceutical Hot Melt Extrusion Sales, Revenue (2019-2023)
15.4.4 Strategic initiatives
16. Conclusion
17. Methodology and Data Source
List of Tables and Figures
Figure 1. Total Sales by Application of Pharmaceutical Hot Melt Extrusion Industry (Volume)
Figure 2. Pharmaceutical Hot Melt Extrusion Sales by Regions in 2023
Figure 3. Regional Market Share in Terms of Revenue (2023&2028)
Figure 4. The Top 10 and 5 Players Market Share by Pharmaceutical Hot Melt Extrusion Revenue in 2023
Figure 5. US Pharmaceutical Hot Melt Extrusion Sales (2019-2028)
Figure 6. Sales Breakdown by Type (%)
Figure 7. Sales Breakdown by Type (%)
Figure 8. Sales Breakdown by Application (%)
Figure 9. Revenue Breakdown by Type (%)
Figure 10. Revenue Breakdown by Application (%)
Figure 11. Europe Pharmaceutical Hot Melt Extrusion Sales (2019-2028)
Figure 12. Sales Breakdown by Type (%)
Figure 13. Sales Breakdown by Type (%)
Figure 14. Sales Breakdown by Application (%)
Figure 15. Revenue Breakdown by Type (%)
Figure 16. Revenue Breakdown by Application (%)
Figure 17. China Pharmaceutical Hot Melt Extrusion Sales (2019-2028)
Figure 18. Sales Breakdown by Type (%)
Figure 19. Sales Breakdown by Type (%)
Figure 20. Sales Breakdown by Application (%)
Figure 21. Current and Estimated Revenue Breakdown by Type
Figure 22. Revenue Breakdown by Type (%)
Figure 23. Revenue Breakdown by Application (%)
Figure 24. Japan Pharmaceutical Hot Melt Extrusion Sales (2019-2028)
Figure 25. Sales Breakdown by Type (%)
Figure 26. Sales Breakdown by Type (%)
Figure 27. Sales Breakdown by Application (%)
Figure 28. Revenue Breakdown by Type (%)
Figure 29. Revenue Breakdown by Application (%)
Figure 30. India Pharmaceutical Hot Melt Extrusion Sales (2019-2028)
Figure 31. Sales Breakdown by Type (%)
Figure 32. Sales Breakdown by Type (%)
Figure 33. Sales Breakdown by Application (%)
Figure 34. Revenue Breakdown by Type (%)
Figure 35. Revenue Breakdown by Application (%)
Figure 36. Korea Pharmaceutical Hot Melt Extrusion Sales (2019-2028)
Figure 37. Sales Breakdown by Type (%)
Figure 38. Sales Breakdown by Type (%)
Figure 39. Sales Breakdown by Application (%)
Figure 40. Revenue Breakdown by Type (%)
Figure 41. Revenue Breakdown by Application (%)
Figure 42. Southeast Asia Pharmaceutical Hot Melt Extrusion Sales (2019-2028)
Figure 43. Current and Estimated Sales Breakdown by Type (2019-2028)
Figure 44. Sales Breakdown by Type (%)
Figure 45. Sales Breakdown by Type (%)
Figure 46. Revenue Breakdown by Type (%)
Figure 47. Revenue Breakdown by Application (%)
Figure 48. Industrial Chain
Table 1. Top Manufacturers and Market Segmentation
Table 2. Product Introduction, Application, Picture
Table 3. Pharmaceutical Hot Melt Extrusion Revenue, by Type (Million USD) (2019-2028)
Table 4. Pharmaceutical Hot Melt Extrusion Sales, by Type (K Unit) (2019-2028)
Table 5. Pharmaceutical Hot Melt Extrusion Sales (K Unit) by Application (2019-2028)
Table 6. Pharmaceutical Hot Melt Extrusion Sales (Million USD) by Application (2019-2028)
Table 7. The Major Downstream Company in China
Table 8. Regional Market Share in Terms of Sales (2023)
Table 9. Regional Market Share in Terms of Revenue (2023&2028)
Table 10. Ranking of Global Top Pharmaceutical Hot Melt Extrusion Companies by Revenue, Concentration Ratio in 2023
Table 11. Mergers & Acquisitions, Expansion Plans
Table 12. US Pharmaceutical Hot Melt Extrusion Sales (K Unit), Market Revenue (Million USD) (2019-2028)
Table 13. Current and Estimated Sales Breakdown by Type (2019-2028)
Table 14. Current and Estimated Sales Breakdown by Type (2019-2028)
Table 15. Current and Estimated Sales Breakdown by Application (2019-2028)
Table 16. Current and Estimated Revenue Breakdown by Type
Table 17. Current and Estimated Revenue Breakdown by Application
Table 18. Europe Pharmaceutical Hot Melt Extrusion Sales (K Unit), Market Revenue (Million USD) (2019-2028)
Table 19. Current and Estimated Sales Breakdown by Type (2019-2028)
Table 20. Current and Estimated Sales Breakdown by Type (2019-2028)
Table 21. Current and Estimated Sales Breakdown by Application (2019-2028)
Table 22. Current and Estimated Revenue Breakdown by Type
Table 23. Current and Estimated Revenue Breakdown by Application
Table 24. China Pharmaceutical Hot Melt Extrusion Sales (K Unit), Market Revenue (Million USD) (2019-2028)
Table 25. Table Current and Estimated Sales Breakdown by Type
Table 26. Current and Estimated Sales Breakdown by Type
Table 27. Current and Estimated Sales Breakdown by Application
Table 28. Current and Estimated Revenue Breakdown by Application
Table 29. Japan Pharmaceutical Hot Melt Extrusion Sales (K Unit), Market Revenue (Million USD) (2019-2028)
Table 30. Current and Estimated Sales Breakdown by Type (2019-2028)
Table 31. Current and Estimated Sales Breakdown by Type (2019-2028)
Table 32. Current and Estimated Sales Breakdown by Application (2019-2028)
Table 33. Current and Estimated Revenue Breakdown by Type
Table 34. Current and Estimated Revenue Breakdown by Application
Table 35. India Pharmaceutical Hot Melt Extrusion Sales (K Unit), Market Revenue (Million USD) (2019-2028)
Table 36. Current and Estimated Sales Breakdown by Type (2019-2028)
Table 37. Current and Estimated Sales Breakdown by Type (2019-2028)
Table 38. Current and Estimated Sales Breakdown by Application (2019-2028)
Table 39. Current and Estimated Revenue Breakdown by Type
Table 40. Current and Estimated Revenue Breakdown by Application
Table 41. Korea Pharmaceutical Hot Melt Extrusion Sales (K Unit), Market Revenue (Million USD) (2019-2028)
Table 42. Current and Estimated Sales Breakdown by Type (2019-2028)
Table 43. Current and Estimated Sales Breakdown by Type (2019-2028)
Table 44. Current and Estimated Sales Breakdown by Application (2019-2028)
Table 45. Current and Estimated Revenue Breakdown by Type
Table 46. Current and Estimated Revenue Breakdown by Application
Table 47. Southeast Asia Pharmaceutical Hot Melt Extrusion Sales (K Unit), Market Revenue (Million USD) (2019-2028)
Table 48. Table Current and Estimated Sales Breakdown by Type (2019-2028)
Table 49. Current and Estimated Sales Breakdown by Application (2019-2028)
Table 50. Current and Estimated Revenue Breakdown by Type
Table 51. Current and Estimated Revenue Breakdown by Application
Table 52. Market Price (USD/Unit) for Each Type of Pharmaceutical Hot Melt Extrusion in US (2019-2023)
Table 53. Market Price (USD/Unit) for Each Type of Pharmaceutical Hot Melt Extrusion in Europe (2019-2023)
Table 54. Market Price (USD/Unit) for Each Type of Pharmaceutical Hot Melt Extrusion in China (2019-2023)
Table 55. Market Price (USD/Unit) for Each Type of Pharmaceutical Hot Melt Extrusion in Japan (2019-2023)
Table 56. Market Price (USD/Unit) for Each Type of Pharmaceutical Hot Melt Extrusion in India (2019-2023)
Table 57. Market Price (USD/Unit) for Each Type of Pharmaceutical Hot Melt Extrusion in Korea (2019-2023)
Table 58. Market Price (USD/Unit) for Each Type of Pharmaceutical Hot Melt Extrusion in Southeast Asia (2019-2023)
Table 59. Key Downstream Customer in Each Application Field
Table 60. Milacron Holdings Profiles
Table 61. Milacron Holdings Pharmaceutical Hot Melt Extrusion Product Introduction
Table 62. Milacron Holdings Pharmaceutical Hot Melt Extrusion Sales (Unit), Revenue (Million USD) (2019-2023)
Table 63. Milacron Holdings Strategic initiatives
Table 64. Coperion GmbH Profiles
Table 65. Coperion GmbH Pharmaceutical Hot Melt Extrusion Product Introduction
Table 66. Coperion GmbH Pharmaceutical Hot Melt Extrusion Sales (Unit), Revenue (Million USD) (2019-2023)
Table 67. Coperion GmbH Strategic initiatives
Table 68. Gabler GmbH&Co. KG Profiles
Table 69. Gabler GmbH&Co. KG Pharmaceutical Hot Melt Extrusion Product Introduction
Table 70. Gabler GmbH&Co. KG Pharmaceutical Hot Melt Extrusion Sales (Unit), Revenue (Million USD) (2019-2023)
Table 71. Gabler GmbH&Co. KG Strategic initiatives
Table 72. Umang Profiles
Table 73. Umang Pharmaceutical Hot Melt Extrusion Product Introduction
Table 74. Umang Pharmaceutical Hot Melt Extrusion Sales (Unit), Revenue (Million USD) (2019-2023)
Table 75. Umang Strategic initiatives
The research methodology employed by VICResearch has been subjected by numerous procedures in order to guarantee the quality and accuracy of the data contained within the reports. The analysts are employed full-time and received more than six months training to satisfy the standard of VICResearch. VICResearch’s methodology can be divided into five stages:
Stage 1: Secondary research
The research team first works with magazines, industry trade group, and administration that operate in the research field. The information provided by our in-house documentation service helps us carrying out further research. Our team which has the experience as well as the knowledge efficiently extracts the accurate information from existing source.
Stage 2: Primary research: interviews with trade sources
After the first stage, the research team conducts large number of face-to-face or telephone interviews with the representative companies operating in the research field. The analysts attempt to obtain a chance to talk with leading players in the field as well as with small companies. The upstream suppliers, manufacturers, distributors, importers, installers, wholesalers and consumers are all included in the interviews. The data gathered during the interview is then carefully checked and compared with the secondary research.
Stage 3: Analysis of the gathered data
The analysis team checks and synthesizes the data gathered during the first two stages. To validate the data, a second series of interviews can be conducted.
Stage 4: Quantitative data
The quantitative data such as market estimates, production and capacity of manufacturer, market forecasts and investment feasibility is provided by VICResearch. The data is based on the estimates obtained during stage 3.
The research team also provides appreciation and analysis of the market and the quantitative data contained in the reports. The data is consequently unique to VICResearch.
Stage 5: Quality control
Before publishing, every report goes under a rigorous checking and editing process, which is done by experience management team to ensure the reliability of the published data. Each analyst in the research team receives support and on-going training which is part of the VICResearch’s internal quality process.
Consulting report: +86-15323335301 020-31521856
